Journal article
Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
Abstract
BACKGROUND: Linaprazan glurate, a potassium-competitive acid blocker, is in development for the treatment of erosive oesophagitis and other acid-related diseases.
AIM: To evaluate the 4-week healing rate and safety of four linaprazan glurate dosing regimens in patients with erosive oesophagitis.
Authors
Sharma P; Vaezi M; Unge P; Andersson K; Larsson K; Popadiyn I; Rosenholm M; Rosztóczy A; Yektaei E; Armstrong D
Journal
Alimentary Pharmacology & Therapeutics, Vol. 61, No. 10, pp. 1590–1602
Publisher
Wiley
Publication Date
5 2025
DOI
10.1111/apt.70109
ISSN
0269-2813